Meera Vaswani*
Volume4-Issue8
Dates: Received: 2023-07-17 | Accepted: 2023-08-10 | Published: 2023-08-11
Pages: 1194-1196
Abstract
Addiction is a major public health problem and millions of people die due to addiction (nicotine, alcohol, and drugs of abuse). The economic consequences of drug addiction are staggering all over the World. Although great strides have been made in understanding the nature of addiction, it is still not well understood. Drug addiction can be considered a chronic brain disease that affects neurotransmission between circuits of neurons that control behavior, emotion and cognition; characterÂized by an excessive engagement in drug use, unsuccessful attempts in controlling drug intake, an increase in anxiety and emotional pain, and inaccurate beliefs about drug use [1]. It is a chronically relapsing disorder characterized by: (a) compulsion to seek and take the drug, (b) loss of control in limiting intake and (c) emergence of a negative emotional state (e.g., dysphoria, anxiety, irritability) when access to the drug is prevented.
FullText HTML
FullText PDF
DOI: 10.37871/jbres1786
Certificate of Publication
Copyright
© 2023 Vaswani M, et al. Distributed under Creative Commons CC-BY 4.0 
How to cite this article
Vaswani M. Addiction: Dispelling Myths. 2023 Aug 10; 4(8): 1194-1196. doi: 10.37871/jbres1786, Article ID: JBRES1785, Available at: https://www.jelsciences.com/articles/jbres1786.pdf
Subject area(s)
References
- Camà J, Farré M. Drug addiction. N Engl J Med. 2003 Sep 4;349(10):975-86. doi: 10.1056/NEJMra023160. PMID: 12954747.
- Volkow ND, Koob GF, McLellan AT. Neurobiologic Advances from the Brain Disease Model of Addiction. N Engl J Med. 2016 Jan 28;374(4):363-71. doi: 10.1056/NEJMra1511480. PMID: 26816013; PMCID: PMC6135257.
- Wise RA, Koob GF. The development and maintenance of drug addiction. Neuropsychopharmacology. 2014 Jan;39(2):254-62. doi: 10.1038/npp.2013.261. Epub 2013 Oct 11. PMID: 24121188; PMCID: PMC3870778.
- Koob GF, Le Moal M. Addiction and the brain antireward system. Annu Rev Psychol. 2008;59:29-53. doi: 10.1146/annurev.psych.59.103006.093548. PMID: 18154498.
- Lüscher C, Malenka RC. Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron. 2011 Feb 24;69(4):650-63. doi: 10.1016/j.neuron.2011.01.017. PMID: 21338877; PMCID: PMC4046255.
- Volkow ND, Fowler JS, Wang GJ. The addicted human brain: insights from imaging studies. J Clin Invest. 2003 May;111(10):1444-51. doi: 10.1172/JCI18533. PMID: 12750391; PMCID: PMC155054.
- Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 2001 Feb;24(2):97-129. doi: 10.1016/S0893-133X(00)00195-0. PMID: 11120394.
- Kelley AE, Berridge KC. The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci. 2002 May 1;22(9):3306-11. doi: 10.1523/JNEUROSCI.22-09-03306.2002. PMID: 11978804; PMCID: PMC6758373.
- Popoli M, Yan Z, McEwen BS, Sanacora G. The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci. 2011 Nov 30;13(1):22-37. doi: 10.1038/nrn3138. PMID: 22127301; PMCID: PMC3645314.
- Corominas M, Roncero C, Casas M. Corticotropin releasing factor and neuroplasticity in cocaine addiction. Life Sci. 2010 Jan 2;86(1-2):1-9. doi: 10.1016/j.lfs.2009.11.005. Epub 2009 Nov 13. PMID: 19914260.
